All

KF* is a tool developed by economists at UVA Darden to estimate the natural level of capital inflows a country should expect to receive. By comparing actual inflows to this benchmark, KF* helps spot early signs of financial risks, like “sudden stops,” and gives policymakers and investors a clearer read on the stability of capital flows.

A landmark study of 60,000+ people across 63 countries reveals how specific messages — from emotional appeals to future-focused thinking — impact climate beliefs, policy support and real action. The key? Tailored strategies, not one-size-fits-all campaigns.

For decades, we have used quantum physics to power MRI machines, solar panels, and lasers. More recently, big tech companies have entered a race to quantum supremacy, where quantum computers surpass silicon-based super computers in speed and complex problem solving. But what is it?

Health care fraud costs the U.S. more than $100 billion annually. Why is that? And how can technology — and specifically artificial intelligence — help us identify problems sooner and potentially help prevent billions in medical fraud and abuse?

Carried interest is once again under scrutiny in Washington. UVA Darden Professor Les Alexander explains what it is, why it's controversial and how proposed changes to its tax treatment could reshape the landscape for private equity and venture capital.

Rising healthcare costs are distorting credit scores, making some borrowers appear more creditworthy than they are. Research from the Mayo Center for Asset Management shows that unreported medical debt leads to higher loan defaults and affects access to credit. Are lenders aware of the risks? What does this mean for borrowers and policymakers?

Computer simulations have been used for decades to predict outcomes. Now digital twins create virtual environments that not only mirror their real-world counterparts but also respond to real-time data to yield more confident decision making.

The secret to driving innovation might not be creating more novelty — but knowing when to strategically scale back. Research from UVA Darden’s Lillien M. Ellis that examines the development of “Avatar,” the biggest box office success in film history, shows that reducing novelty in some areas leads to greater creative and commercial success.

A new business case on infamous tech company Theranos examines the risks for entrepreneurs, board members and investors in the fog of the innovation economy.